NRC Health Operating Lease Liability
NRC Health (NRC) had Operating Lease Liability of $1.20 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-05
- 2025-12-31: Operating Lease, Liability $1.20M.
- 2024-12-31: Operating Lease, Liability $1.71M.
- 2023-12-31: Operating Lease, Liability $2.23M.
- 2019-09-30: Operating Lease, Liability $1.84M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $1.20M 10-K · filed 2026-03-05 |
| 2024-12-31 | $1.71M 10-K · filed 2026-03-05 |
| 2023-12-31 | $2.23M 10-K · filed 2025-03-17 |
| 2019-09-30 | $1.84M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $2.02M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $2.19M 10-Q · filed 2019-05-08 |
| 2019-01-01 | $2.35M 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |